From Industry Trends to Infrastructure Decisions: Planning for Life Sciences Facility Needs



How proactive MEP/FP engineering and building commissioning can help life sciences organizations address industry challenges.

Representatives from Wick Fisher White attended the Philadelphia Business Journal's 2026 State of the Biotech Industry event on October 22, where industry leaders discussed pharmaceutical manufacturing investments, scientific innovation, funding challenges, and emerging technologies.

These discussions highlighted several developments shaping Pennsylvania's life sciences industry. From an engineering perspective, these trends have important implications for facility planning, infrastructure investments, and long-term operational needs.

As manufacturing expands, capital remains constrained, and production technologies advance, early engineering involvement can help life sciences organizations anticipate infrastructure challenges, evaluate their options, and make informed facility decisions.

Manufacturing Investment Is Driving Infrastructure Needs


Involving MEP/FP engineers early in project planning helps establish whether proposed building systems can support manufacturing requirements…

Jeff Marrazzo, co-founder and former CEO of Spark Therapeutics, highlighted $8.7 billion in new manufacturing projects and expansions involving six companies in Pennsylvania over a 12-month period.

This level of investment creates opportunities for new construction and facility expansion, but it also places greater importance on coordinating manufacturing requirements with building infrastructure. Specialized production equipment can significantly influence electrical capacity, HVAC design, utility distribution, environmental controls, and system redundancy.

Involving MEP/FP engineers early in project planning helps establish whether proposed building systems can support manufacturing requirements before major design and construction decisions are made. This includes evaluating equipment loads, utility availability, infrastructure capacity, and potential expansion needs.

Identifying these requirements early can reduce redesign, prevent costly infrastructure modifications, and help owners establish more realistic project budgets and schedules.

Capital Efficiency Is Influencing Facility Decisions


Despite advances in scientific research, panelists emphasized ongoing funding pressures and the importance of capital efficiency.

For life sciences organizations evaluating new laboratories, manufacturing expansions, or facility renovations, these financial pressures make infrastructure assessments an important part of capital planning.

An existing building may offer sufficient space for a proposed operation but lack the HVAC capacity, electrical infrastructure, or specialized utilities required to support it. Without an early assessment, these limitations may not become apparent until design or construction is underway.

MEP/FP infrastructure assessments help owners understand the feasibility and cost implications of adapting existing facilities before committing significant capital. Identifying capacity constraints, equipment conditions, and required upgrades can inform decisions about renovation versus new construction, project phasing, and infrastructure investments.

Retro-commissioning provides another opportunity to manage capital expenditures by identifying operational deficiencies and improvements that may enhance existing system performance without requiring full equipment replacement.

Automation Is Changing Specialized Manufacturing


Proactive MEP/FP engineering can help owners plan infrastructure that accommodates future equipment changes and production requirements.

Gwendolyn Binder, President of Cabaletta Bio, discussed how advances in automation are helping reduce costs and increase flexibility in cell therapy manufacturing.

As manufacturing processes become more automated, changes in production equipment and workflows can affect electrical loads, cooling requirements, environmental controls, and utility connections. Facilities designed around current equipment configurations may face costly modifications when manufacturing processes change.

Proactive MEP/FP engineering can help owners plan infrastructure that accommodates future equipment changes and production requirements. Evaluating available system capacity, flexible utility distribution, and building automation capabilities during design can reduce disruptions and the cost of future modifications.

Commissioning is particularly valuable in facilities where environmental conditions and system reliability are critical to operations. Functional performance testing helps verify that HVAC equipment, environmental controls, and building automation systems operate as intended before research or manufacturing activities begin, reducing the risk of operational disruptions and corrective work.

Engineering for What's Next


For facility owners, these developments make early infrastructure planning increasingly important. Identifying building system limitations, anticipating future requirements, and verifying system performance can help organizations manage costs, reduce operational risks, and make better use of infrastructure investments.

Wick Fisher White supports laboratory, pharmaceutical, and life science facilities through MEP/FP engineering design, infrastructure assessments, and building commissioning. By addressing infrastructure challenges early, Wick Fisher White helps clients make informed capital decisions and develop reliable building systems that support both current operations and future facility needs.


Marketing